5 ESSENTIAL ELEMENTS FOR TRASTUZUMAB SEQUENCE

The most beneath-investigated “driving forces” involved in trastuzumab resistance is PTEN. Nagata et al. (2004) claimed that the loss of PTEN was noticed in 36% of HER2-constructive Main breast tumor specimens from sufferers with phase IV ailment. Additionally, they also showed that individuals with PTEN-deficient tumors experienced remarkably